Location History:
- Jiangsu, CN (2018)
- Zhenjiang, CN (2021 - 2023)
Company Filing History:
3 out of 3 
2 out of 2 Years Active: 2018-2023
Title: Innovations by Zhongyi Geng
Introduction
Zhongyi Geng is a notable inventor based in Zhenjiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor drugs. With a total of 3 patents to his name, Geng's work focuses on innovative drug formulations that enhance therapeutic efficacy.
Latest Patents
One of Geng's latest patents is a ketone carbonyl-containing hydrophobic antitumor drug and its conjugate, along with a nano preparation containing the conjugate. This invention provides a novel approach to cancer treatment by utilizing an amphipathic pH-responsive conjugate. The conjugate is formed through a dehydration condensation reaction between a hydrazide-terminated polyethylene glycol and a hydrophobic antitumor drug. This innovative drug formulation demonstrates higher antitumor activity compared to existing treatments like docetaxel.
Another significant patent by Geng is the 1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative. This compound exhibits good gastric acid secretion inhibitory activities and excellent pharmacodynamic properties, while maintaining relatively low toxicity. These advancements highlight Geng's commitment to developing effective and safer pharmaceutical solutions.
Career Highlights
Zhongyi Geng has worked with prominent companies in the pharmaceutical industry, including Jiangsu Jibeier Pharmaceutical Co. Ltd. and Zhenjiang San an Pharmaceutical Co. Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Geng has collaborated with notable colleagues such as Xinghai Chen and Deyue Yan. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Zhongyi Geng's contributions to pharmaceutical innovations, particularly in antitumor drug development, demonstrate his significant impact on the field. His patents reflect a dedication to improving cancer treatment options and advancing medical science.